bromocriptine has been researched along with Cardiomyopathy, Dilated in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ketineni, S; Potu, KC; Raizada, A; Stys, A; Stys, M | 1 |
| Cemin, R; Daves, M; Donazzan, L; Janardhanan, R | 1 |
| Asanin, M; Cetković, A; Kotlica, BK; Macut, D; Plesinac, S | 1 |
| Hamdan, R; Issa, M; Mansour, H; Nassar, P; Saab, M; Zein, A | 1 |
| Emmert, MY; Falk, V; Krähenmann, F; Prêtre, R; Ruschitzka, F; Wilhelm, MJ | 1 |
| Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S | 1 |
2 review(s) available for bromocriptine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Peripartum Cardiomyopathy: Literature Review.
Topics: Adrenergic beta-Antagonists; Anticoagulants; Bromocriptine; Cardiomyopathy, Dilated; Delivery, Obstetric; Diuretics; Dopamine Agonists; Electric Countershock; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors | 2016 |
Peripartum cardiomyopathy: moving towards a more central role of genetics.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bromocriptine; Cardiomyopathy, Dilated; Echocardiography; Female; Genetic Predisposition to Disease; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Twin; Prognosis; Risk Factors; Treatment Outcome | 2013 |
4 other study(ies) available for bromocriptine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Peripartum cardiomyopathy: a case of patient with triplet pregnancy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anticoagulants; Bromocriptine; Cardiomyopathy, Dilated; Cesarean Section; Diuretics; Female; Heart Failure; Heparin; Hormone Antagonists; Humans; Peripartum Period; Pregnancy; Pregnancy, Triplet; Puerperal Disorders; Respiration, Artificial | 2016 |
Peripartum cardiomyopathy, place of drug therapy, assist devices, and outcome after left ventricular assistance.
Topics: Adult; Bromocriptine; Cardiomyopathy, Dilated; Device Removal; Diagnosis, Differential; Dopamine Agonists; Female; Heart-Assist Devices; Humans; Perinatal Care; Peripartum Period; Pregnancy; Puerperal Disorders | 2017 |
Peripartum cardiomyopathy with cardiogenic shock: recovery after prolactin inhibition and mechanical support.
Topics: Adult; Bromocriptine; Cardiomyopathy, Dilated; Female; Heart-Assist Devices; Hormone Antagonists; Humans; Puerperal Disorders; Shock, Cardiogenic | 2011 |
[Gender effect on cardiomyopathy].
Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome | 2012 |